3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
13
Neoplasms
6
Breast Neoplasms
3
Advanced Solid Tumor
3
Sarcoma
2
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Solid Tumors
2
Stomach Neoplasms
1
Solid Tumors
1
Sarcoma, Ewing
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma
1
Major Advanced Solid Tumors Other Than Colorectal
1
Lung Neoplasms
1
Leukemia
1
Leiomyosarcoma
1
Glioblastoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Endometrial Neoplasms
1
Carcinoma, Small Cell
1
Carcinoma, Ovarian Epithelial
1
ADVANCED SOLID TUMORS
1
Interventions
sacituzumab govitecan
1
amrubicin
1
Topotecan
1
PM 01183
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
×
PM 01183
×
Clear all
NCT06801834
2026-05-20
EVOKE-SCLC-04
Gilead Sciences
Phase 3
Recruiting
695 enrolled